Misdiagnosis in EDS

https://www.mdpi.com/2227-9067/12/6/698

‍

‍

1.       Singh, H., & Sittig, D. F. (2015). Advancing the science of measurement of diagnostic errors in healthcare: the Safer Dx framework. BMJ Quality & Safety, 24(2), 103-110.

2.       National Academy of Medicine. (2015). Improving Diagnosis in Health Care. Washington, DC: National Academies Press.

3.       Tehrani, A. S. A., Lee, H., Mathews, S. C., Shore, A., Makary, M. A., & Pronovost, P. J. (2013). 25-year summary of US malpractice claims for diagnostic errors 1986–2010. BMJ Quality & Safety, 22(8), 672-680.

4.       Aronin, S. I., Peduzzi, P., & Quagliarello, V. J. (1998). Community-acquired bacterial meningitis: risk stratification for adverse clinical outcome and effect of antibiotic timing. Annals of Internal Medicine, 129(11), 862-869.

5.       Bell, R. A., Kravitz, R. L., & Wilkes, M. S. (2001). Direct-to-consumer prescription drug advertising and the public. The Journal of Family Practice, 50(6), 427-432.

6.       Feder, H. M., Johnson, B. J., O’Connell, S., et al. (2007). A critical appraisal of "chronic Lyme disease". New England Journal of Medicine, 357(14), 1422-1430.

7.       Zwaan, L., & Singh, H. (2015). The challenges in defining and measuring diagnostic error. Diagnosis, 2(2), 97-103.

8.       Bishop, T. F., Ryan, A. M., & Casalino, L. P. (2011). Paid malpractice claims for adverse events in inpatient and outpatient settings. JAMA, 305(23), 2427-2431.

9.       Schwappach, D. L. B. (2010). Engaging patients as vigilant partners in safety: a systematic review. Medical Care Research and Review, 67(2), 119-148.

10.     Reardon, W. (2011). The rare disease paradox. European Journal of Human Genetics, 19(10), 1085-1089.

11.     Croskerry, P. (2003). The importance of cognitive errors in diagnosis and strategies to minimize them. Academic Medicine, 78(8), 775-780.

‍